Roentgen Stereophotogrammetric Analysis (RSA) Trial Comparing Trabecular Metal Monoblock and Modular Tibial Components
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01180595 |
Recruitment Status :
Completed
First Posted : August 12, 2010
Last Update Posted : August 21, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Total knee replacement is an effective option for treating chronic knee conditions that cause pain and functional impairment. Significant improvements in quality of life, as measured by both disease specific and generic quality of life measures have been well documented. Carefully monitored introduction of new implant designs through small, randomized trials using radiostereometric analysis (RSA) is gaining support. RSA is a radiographic technique that uses small tantalum balls implanted into the patient's bone to measure micromotion (<1 mm) at the bone - implant interface, something which is not possible to do reliably using regular x-ray techniques. The amount of micromotion that occurs within 2 years of surgery can be used to predict the long term survival of knee replacements. This provides a method for detecting inferior implant designs using only a small number of patients before release of these products into large clinical trials.
The study purpose is to utilize RSA to compare the migration patterns of the Trabecular Metal(TM) Monoblock and the TM Modular Total Knee Arthroplasties during the first two postop years and to determine what proportion of cases achieve adequate fixation. Secondary outcome measures will be recorded to quantify changes in functional status of subjects after surgery and bone mineral density will be monitored to quantify any changes around the implant. Migration patterns will be compared to results obtained from previous studies of uncemented and cemented total knee arthroplasty components conducted at this centre.
Null Hypothesis: There is no significant difference in micromotion patterns of the TM arthroplasty components of the monoblock design and the modular design.
Alternative Hypothesis: There are significant differences in micromotion patterns between the tibial components of the monoblock design and the modular design.
This is a consecutive sample randomized control trial of patients undergoing total knee arthroplasty with the TM Monoblock and TM Modular Knee Arthroplasty systems utilizing RSA to identify the migration patterns of the tibial components of the implant. DEXA scanning will also be conducted to determine changes in the bone mineral density adjacent to the implant. Health status and functional outcome measures will be recorded to quantify functional status of subjects before surgery and at each follow-up interval. Gait will be monitored and analyzed preoperatively and postoperatively throughout the duration of the trial.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Osteoarthritis | Device: Trabecular Metal Modular Tibial Total Knee Component Device: Trabecular Metal Monoblock Tibial Total Knee Component | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 50 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Randomized Control Study Using Roentgen Stereophotogrammetric Analysis (RSA) to Compare the Fixation of the Trabecular Metal Monoblock and the Trabecular Metal Modular Total Knee Arthroplasties |
Study Start Date : | February 2011 |
Actual Primary Completion Date : | September 2019 |
Actual Study Completion Date : | September 2019 |

Arm | Intervention/treatment |
---|---|
Modular
Trabecular Metal Modular Tibial Total Knee Component
|
Device: Trabecular Metal Modular Tibial Total Knee Component
The modular design of the Trabecular Metal Total Knee allows for increased options for physicians however, it is not clear how this modular feature will affect fixation since it may compromise some of the advantages of the original TM Monoblock tibial component. |
Monoblock
Trabecular Metal Monoblock Tibial Total Knee Component
|
Device: Trabecular Metal Monoblock Tibial Total Knee Component |
- micromotion of tibial component as measured with RSA [ Time Frame: 2 years postoperative ]
- Bone mineral density around the tibial component [ Time Frame: 2 years postoperative ]
- Subjective health outcome questionnaires - SF36, WOMAC, Oxford12 knee, Pain and Catastrophizing Scale, Standardized comorbidity questionnaire [ Time Frame: 2 years postoperative ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Symptomatic osteoarthritis of the knee indicating surgical intervention
- Between the ages of 21 and 80 inclusive
- Ability to give informed consent
Exclusion Criteria:
- Significant co-morbidity affecting ability to ambulate
- Flexion contracture greater than 15°
- Extension lag greater than 10°
- Tibial subluxation greater than 10 mm on standing AP radiograph
- Prior arthroplasty, patellectomy or osteotomy with the affected knee
- Lateral or medial collateral ligament instability (> 10° varus/valgus)
- Leg length discrepancy greater than 10 mm
- Active or prior infection
- Morbid Obesity (BMI > 40)
- Medical condition precluding major surgery
- Severe osteoporosis or osteopenia
- Neuromuscular impairment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01180595
Canada, Nova Scotia | |
Halifax Infirmary | |
Halifax, Nova Scotia, Canada, B3H 3A7 |
Principal Investigator: | Michael J Dunbar, MD PhD | Dalhousie University and CDHA |
Responsible Party: | Michael Dunbar, MD, PhD, Dalhousie University |
ClinicalTrials.gov Identifier: | NCT01180595 |
Other Study ID Numbers: |
CDHA-RS/2011-010 |
First Posted: | August 12, 2010 Key Record Dates |
Last Update Posted: | August 21, 2020 |
Last Verified: | August 2020 |
osteoarthritis arthroplasty knee joint radiography |
surgery Bone Density Outcome Assessment (Health Care) |
Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |